Anemia in chronic heart failure: can we treat? What to treat? (Q37943240)

25 August 2017

1 reference

title

Anemia in chronic heart failure: can we treat? What to treat? (English)

1 reference

25 August 2017

0 references

chronic heart failure

1 reference

1

Stephan von Haehling

1 reference

25 August 2017

3

Ewa A Jankowska

1 reference

25 August 2017

4

Piotr Ponikowski

1 reference

25 August 2017

5

Stefan D Anker

1 reference

25 August 2017

2

Markus S Anker

1 reference

25 August 2017

publication date

1 March 2012

1 reference

25 August 2017

published in

Heart Failure Reviews

1 reference

25 August 2017

volume

17

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

203-210

1 reference

Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Altered intestinal function in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Cachexia as a major underestimated and unmet medical need: facts and numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Bone marrow dysfunction in chronic heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia in heart failure: an overview of current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Pathophysiology and treatment of inflammatory anorexia in chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia in chronic heart failure: etiology and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Strategies for the laboratory diagnosis of some common causes of anaemia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia and mortality in heart failure patients a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Etiology of anemia in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Ferric carboxymaltose in patients with heart failure and iron deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Venous thromboembolic events and erythropoiesis-stimulating agents: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10741-011-9283-X

Anemia in chronic heart failure: pathogenetic mechanisms

21 January 2018

1 reference

12 December 2020

Intravenous iron alone for the treatment of anemia in patients with chronic heart failure

1 reference

12 December 2020

Strategies for iron supplementation: oral versus intravenous

1 reference

12 December 2020

Diagnosis and management of iron deficiency anaemia: a clinical update

1 reference

12 December 2020

Role of iron in optimizing responses of anemic cancer patients to erythropoietin.

1 reference

12 December 2020

Erythropoietin: physiology and pharmacology update

1 reference

12 December 2020

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

12 December 2020

Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well

1 reference

12 December 2020

Anaemia is an independent predictor of poor outcome in patients with chronic heart failure

1 reference

12 December 2020

Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.

1 reference

12 December 2020

Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?

1 reference

12 December 2020

Structure, chemistry, and pharmacokinetics of intravenous iron agents

1 reference

12 December 2020

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure

1 reference

12 December 2020

10.1007/S10741-011-9283-X

Identifiers

DOI

1 reference

25 August 2017

1 reference